Profluent, Supported by Salesforce Research and Jeff Dean, Harnesses AI for Drug Discovery
The initiative by Salesforce called ProGen aimed to utilize generative AI to design proteins, potentially revolutionizing medical treatments by uncovering them more cost-effectively than traditional methods. While ProGen resulted in research showing successful creation of artificial protein structures, it didn’t progress much commercially. Devamını Oku